Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...

KLOXXADO ® delivers 8 mg of naloxone hydrochloride per spray in a ready to use nasal spray to reverse the effects of opioid overdose.

Nasal spray shows preclinical promise for treating traumatic brain injury. ScienceDaily . Retrieved March 18, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250227125519.htm ...

Soft Mist Nasal Spray Technology Designed to Enhance Drug Deposition in the Olfactory Region, Increasing the Potential for CYR-064's Therapeutic Efficacy DELRAY BEACH, Fla and ENSCHEDE ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...

The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for ...

A nighttime nasal spray may offer a new way to ease sleep apnea and lower blood pressure, according to Australian researchers ...

CINCINNATI (WKRC) - The Food and Drug Administration issued a recall for certain nasal spray that tested positive for a bacterial contaminate that could lead to "potentially life-threatening ...

Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...

A batch of SinuCleanse nasal wash has been recalled nationwide due to Staphylococcus aureus contamination. The bacteria can cause staph infections, which can have serious and potentially life ...